NDC 59762-1350

Rifabutin

Rifabutin

Rifabutin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Greenstone Llc. The primary component is Rifabutin.

Product ID59762-1350_310f1ea7-e7b8-4afe-87ee-38d7abf5cbd5
NDC59762-1350
Product TypeHuman Prescription Drug
Proprietary NameRifabutin
Generic NameRifabutin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2014-04-07
Marketing CategoryNDA / NDA
Application NumberNDA050689
Labeler NameGreenstone LLC
Substance NameRIFABUTIN
Active Ingredient Strength150 mg/1
Pharm ClassesRifamycin Antimycobacterial [EPC],Rifamycins [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 59762-1350-1

100 CAPSULE in 1 BOTTLE (59762-1350-1)
Marketing Start Date2014-04-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59762-1350-1 [59762135001]

Rifabutin CAPSULE
Marketing CategoryNDA
Application NumberNDA050689
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-04-07

Drug Details

Active Ingredients

IngredientStrength
RIFABUTIN150 mg/1

OpenFDA Data

SPL SET ID:c2026b67-4755-4236-96b6-a6b5e7399707
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198200
  • Pharmacological Class

    • Rifamycin Antimycobacterial [EPC]
    • Rifamycins [CS]
    • Rifamycin Antimycobacterial [EPC]
    • Rifamycins [CS]

    Medicade Reported Pricing

    59762135001 RIFABUTIN 150 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Rifabutin" or generic name "Rifabutin"

    NDCBrand NameGeneric Name
    10135-738RifabutinRifabutin
    59762-1350Rifabutinrifabutin
    60687-198rifabutinrifabutin
    68180-285rifabutinrifabutin
    70954-041RifabutinRifabutin
    0013-5301Mycobutinrifabutin
    55695-010Mycobutinrifabutin

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.